Davos 2017 - Feel Better or Your Money Back
<p><a rel="nofollow" class="external free" href="http://www.weforum.org/">http://www.weforum.org/</a>
This year saw the launch of a one-shot gene therapy with a money-back guarantee should the treatment not work. Is the time ripe for a new era of drug pricing based on patient outcome?
</p><p>- Lloyd Dean, President and Chief Executive Officer, Dignity Health, USA
- Omar Ishrak, Chairman and Chief Executive Officer, Medtronic, USA
- Joseph Jimenez, Chief Executive Officer, Novartis, Switzerland
- Risa Lavizzo-Mourey, Chief Executive Officer and President, Robert Wood Johnson Foundation (RWJF), USA
- Steve Rusckowski, Chairman, President and Chief Executive Officer, Quest Diagnostics, USA
</p><p>Moderated by
</p>
- Allison Aubrey, Correspondent, National Public Radio, USA
<a rel="nofollow" class="external text" href="https://www.youtube.com/channel/UCw-kH-Od73XDAt7qtH9uBYA">World Economic Forum</a>
CC BY 3.0
<a rel="nofollow" class="external text" href="https://www.youtube.com/watch?v=d3UmZS0ZCG8">Davos 2017 - Feel Better or Your Money Back</a>